Related Experiment Video
Updated: Apr 13, 2026

A Semi-Automated and Reproducible Biological-Based Method to Quantify Calcium Deposition In Vitro
Published on: June 2, 2022
[Vascular Calcification - Pathological Mechanism and Clinical Application - . Vascular calcification in chronic
Momoyo Omata1, Masafumi Fukagawa, Takatoshi Kakuta
1Department of Internal Medicine, Hachioji Azumacho Clinic, Tokyo, Japan.
Insights
Chronic kidney disease-mineral and bone disorder (CKD-MBD) involves bone and vascular issues, increasing cardiovascular mortality risk. Early intervention targeting FGF23 and phosphate is crucial for better CKD patient outcomes.
Area of Science:
- Nephrology
- Endocrinology
- Cardiovascular Medicine
Background:
- Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a progressive condition impacting bone health and vasculature.
- Vascular calcification in CKD patients is a significant contributor to cardiovascular disease and mortality.
- Elevated FGF23 levels are linked to increased mortality, vascular calcification, and CKD progression.
Purpose of the Study:
- To highlight the critical role of CKD-MBD in cardiovascular complications.
- To emphasize the association between FGF23, vascular calcification, and mortality in CKD.
- To underscore the necessity of early therapeutic interventions for CKD-MBD.
Main Methods:
- Literature review of studies investigating CKD-MBD pathophysiology.
- Analysis of the relationship between serum FGF23, klotho, phosphate, and PTH levels in early CKD.
- Examination of the impact of vascular calcification on cardiovascular outcomes in dialysis patients.
Main Results:
- CKD-MBD encompasses laboratory, bone, and vascular abnormalities.
- Cardiovascular disease accounts for over 40% of deaths in dialysis patients, linked to arteriosclerosis and vascular calcification.
- Despite normal phosphate levels in early CKD due to FGF23 and PTH upregulation, renal insufficiency reduces klotho.
Conclusions:
- Vascular calcification is a key pathophysiological mechanism driving cardiovascular disease and mortality in CKD patients.
- Serum FGF23 concentration is a significant predictor of mortality, vascular calcification, and CKD progression.
- Early management of CKD-MBD is essential to improve patient prognosis and mitigate cardiovascular risks.
Abstract:
Chronic kidney disease-mineral and bone disorder (CKD-MBD), is sequential pathophysiology that starts in the very early stages of CKD. Three major aspects of CKD-MBD are laboratory abnormalities, bone abnormalities and vascular calcification. In dialysis patients, the prevalence of death due to cardiovascular disease accounts for more than 40% of all-cause mortality. Therefore, arteriosclerosis with vascular calcification may be an important pathophysiological mechanism in the development of cardiovascular disease. Vascular calcification is known to be an important risk factor influencing mortality in CKD patients. A number of studies have suggested a close association between serum FGF23 concentration and the risks of mortality, cardiovascular disease vascular calcification as well as CKD progression. Renal insufficiency leads to decline in klotho level and impaired phosphate excretion. However serum phosphate levels are maintained in the normal range by up regulation of FGF23 and PTH in early CKD stage. Early treatment intervention is necessary to improve the prognosis of the CKD patient.
Related Concept Videos
Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease III: Interprofessional Care
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations
Skeleton and Calcium Homeostasis
Chronic Kidney Disease IV: Nursing Management

